Successful as prophylaxis when other drug therapies are exhausted with Erenumab in November 2018 the first medication of a new class for the prophylaxis of migraines on the German market. In an early benefit assessment, [...]
Kiel, January 16, 2019. The journal *Der Schmerz* (Pain) published today the first scientific analysis of the treatment behavior of migraine and headache patients using digital therapy support with the migraine app. This is the first scientific publication on the application [...]
London, 10 January 2019. The National Institute for Health and Care Excellence (NICE) is assessing guidance on health technologies, clinical practice and prevention for the UK Department of Health. The [...]
How often do migraines appear in children? 73.9 percent of seventh graders complain about primary headaches. The most common forms are migraines and headache from the tension type. Almost 50 % of those affected report symptoms of migraines [...]
The migraines worldwide behind Zahnkaries and headache from the type of voltage occupies the 3rd place of the most common diseases of humans [28]. The one-year prevalence in Europe for all forms of migraines is 43.6% in women and 26.9% [...]
. Germany's academic offspring are struggling headaches. Around 1.8 of the 2.8 million students in Germany suffer. Almost every third of them are seriously impaired by headaches. That is the highest severity [...]
The pain clinic Kiel is the new partner of the growing, cross -carrier quality network "We für Health". The network includes more than 220 selected partner clinics and a variety of outpatient facilities across Germany, the above-average treatment and service quality [...]
The 3rd edition of the international classification of headache diseases (IchD-3) is now also available in its final form in the German translation. It can be viewed on the homepage of the IchD-3 via the link https://www.ichd-3.org/ichd-3-translations/. Particularly [...]
The diseases headache and migraine not only affect the lives of those affected, but also cause economic damage. Newly developed antibodies intervene specifically in the molecular development process of migraines and can therefore preventively reduce the likelihood [...]
The first week of September is used internationally to educate people about migraines in order to raise awareness of the great importance of the health problem. Prejudices and stigmas should be reduced. Prof. Hartmut Göbel answers current questions about migraines, their effects [...]
Kiel, August 1st, 2018. The Prime Minister of Schleswig-Holstein, Daniel Günther, presented today in the presence of the Minister of Health Dr. Heiner Garg and district president Dr. Juliane Rumpf and numerous guests of honor received the Cross of Merit 1st awarded to her by Federal President Frank-Walter Steinmeier.
July 30, 2018. The migraine immunotherapy with the active ingredient erenumab (Aimovig) can now also be sold in the EU. The US approval was initially given in May 2018, followed by approval in Switzerland in July. Now the [...]
In the FAZ study "Germany's best hospitals", the Kiel pain clinic takes on the top position among the specialized inpatient pain therapy clinics nationwide. In relation to all around 2000 hospitals in Germany, she was among the 10 best clinics [...]
Cambridge MA, USA, Kiel, June 22, 2018. In the most comprehensive international collaboration to date on the molecular-genetic basis of diseases of the central nervous system, the international research consortium with the participation of scientists from the Kiel Pain Clinic discovered genetic [...]
Tension-type headaches are the most common type of headache. Local topical treatment with peppermint oil (Oleum menthae piperitae) has proven significantly effective compared to placebo in controlled studies. Peppermint oil acts through numerous mechanisms of action [...]
May 17, 2018. On May 17, 2018, the US Food and Drug Administration (FDA) approved Aimovig (erenumab-AOOE) for the preventative treatment of migraine in adults. The treatment is carried out by self-injecting the drug under the skin [...]
Headaches are a common problem. 54 million people in Germany are affected. Dr. Heinz-Wilhelm Esser meets headache patients. During his visit to the Kiel Pain Clinic, he found out about, among other things, the causes of migraines and headaches, [...]
In these click tips, Prof. Hartmut Göbel from the Kiel Pain Clinic shows you how the migraine app analyzes the course of treatment individually, supports and optimizes the treatment. In the list below you will find the complete series of all [...]
With the current update of the migraine app from the Kiel Pain Clinic and the Techniker Krankenkasse (TK), many new functions are available. These are intended to help those affected to better classify headache attacks and to distinguish them from other neurological diseases.
The new migraine app from the Kiel Pain Clinic and the Techniker Krankenkasse is a comprehensive documentation, analysis, information and treatment tool for migraines and headaches. It was developed in collaboration with scientists, migraine and headache experts, those affected, self-help groups and health care experts.
